haloperidol has been researched along with clomipramine in 78 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 34 (43.59) | 18.7374 |
1990's | 13 (16.67) | 18.2507 |
2000's | 18 (23.08) | 29.6817 |
2010's | 12 (15.38) | 24.3611 |
2020's | 1 (1.28) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Costanzo, MJ; Gardocki, JF; Maryanoff, BE; McComsey, DF; Nortey, SO; Schneider, CR; Setler, PE; Shank, RP | 1 |
Lucas, RA; Smith, RG; Wasley, JW | 1 |
Topliss, JG; Yoshida, F | 1 |
Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Abraham, MH; Acree, WE; Ibrahim, A | 1 |
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Ang, KK; Arkin, MR; Chen, S; Doyle, PS; Engel, JC; McKerrow, JH | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Atzpodien, EA; Csato, M; Doessegger, L; Fischer, H; Lenz, B; Schmitt, G; Singer, T | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Artursson, P; Mateus, A; Matsson, P | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Kocher, R | 4 |
Balsara, JJ; Chandorkar, AG; Jadhav, JH | 1 |
Morselli, PL; Zarifian, E | 1 |
Clineschmidt, BV; McGuffin, JC; Pflueger, AB; Totaro, JA | 1 |
Krupp, P; Wesp, M | 1 |
Donahoe, DH; Fortune, T; Llorena, R; Meador, M | 1 |
Hirayama, M; Nisijima, K | 1 |
Höffken, K; Kloke, M; Olbrich, H; Schmidt, CG | 1 |
Futuro-Neto, HA; Pires, JG; Silva, SR | 1 |
Cohen, PR; Cowen, PJ; McCance, SL | 1 |
Panerai, AE; Sacerdote, P | 1 |
Arbogast, R; Krimmer, H; Pfeiffer, H; Sprotte, G | 1 |
Hölzl, G; Krüger, R; Kuss, HJ; Schefold, L | 1 |
Ansseau, M; Dresse, AE; Franck, G; Kupfer, DJ; Poncelet, PF; Reynolds, CF; Reznik, M | 1 |
Gotouda, H; Mizukami, K; Nagao, M; Takatori, T | 1 |
Gorynia, I; Seidel, M | 1 |
Ananth, J | 1 |
Fischer, W; Heydenreich, F; Rabending, G; Streubel, FR | 1 |
Ostergaard, PK | 1 |
Clineschmidt, BV; Mcguffin, JC; Werner, AB | 1 |
Kocher, R; Rohrer, G | 1 |
Bianchetti, G; Dugas, M; Morselli, PL | 1 |
Burkard, WP; Da Prada, M; Keller, HH | 1 |
Davies, JA; Graham, JD | 1 |
Herberger, B; Kissling, W; Kuss, HJ; Möller, HJ | 1 |
Aschauer, H; Koinig, G; Langer, G; Resch, F; Schönbeck, G | 1 |
Aschauer, H; Dittrich, R; Keshavan, MS; Koinig, G; Langer, G; Resch, F; Schönbeck, G | 1 |
Baran, L; Bigajska, K; Przegaliński, E; Siwanowicz, J | 1 |
Bottermann, P; Kissling, W; Möller, HJ | 1 |
Amabile, G; Balestrieri, A; Bedarida, D; Benecchi, MV; Burti, L; Cassano, GB; Castrogiovanni, P; Catalano, A; Cerone, G; Guidotti, N; Marchetti, FP; Mauri, M; Nielsen, NP; Pariante, F; Pirro, R; Pugliese, L; Reitano, S; Rocco, ML; Rutigliano, G; Tansella, M; Zanasi, M | 1 |
Andreas, K; Engert, U; Fischer, HD | 1 |
Adams, PB; Campbell, M; Hallin, A; Sanchez, LE; Small, AM; Uysal, S | 1 |
Goodman, WK; McDougle, CJ; Price, LH | 1 |
Corbett, R; Cornfeldt, M; Dunn, RW; Smith, C; Szewczak, M; Woods, A | 1 |
Ishikura, T; Jibiki, I; Kubota, T | 1 |
Olds, ME | 1 |
Bernardo, M; Escobar, R | 1 |
Dryden-Edwards, RC; Reiss, AL | 1 |
Leonard, HL | 1 |
Bizot, JC | 1 |
Gow, R; Konstantareas, M; Parker, K; Remington, G; Sloman, L | 1 |
Hatzimanolis, J; Lykouras, L; Markianos, M | 3 |
Angelopoulos, EK; Daskalopoulou, EG; Hatzimanolis, J; Markianos, M; Tzemos, J | 1 |
Christodoulou, GN; Hatzimanolis, J; Lykouras, L; Markianos, M | 1 |
Fay, G; King, R; Wheildon, H | 1 |
Amato, D; Borsini, F; Nencini, P; Stasi, MA | 1 |
Albright, JD; Hickam, HD; Lynch, MJ; Morrisey, JK; Starkey, SR | 1 |
De Carolis, L; Milella, MS; Nencini, P; Schepisi, C | 1 |
Nakamae, T | 1 |
Coffman, CF; Fiacco, NR; Granger, JC; Helton, BM; Jackson, JC; Kim, LV; Kreiss, DS; Mistry, RS; Mizer, TM; Palmer, LV; Vacca, JA; Winkler, SS; Zimmer, BA | 1 |
5 review(s) available for haloperidol and clomipramine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clomipramine: an antiobsessive drug.
Topics: Anxiety; Behavior Therapy; Clinical Trials as Topic; Clomipramine; Compulsive Behavior; Depressive Disorder; Diazepam; Haloperidol; Humans; Imipramine; Nortriptyline; Obsessive Behavior; Obsessive-Compulsive Disorder; Phobic Disorders; Psychological Tests | 1986 |
Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder.
Topics: Adult; Antipsychotic Agents; Clinical Trials as Topic; Clomipramine; Clozapine; Dopamine Antagonists; Drug Therapy, Combination; Female; Fluvoxamine; Haloperidol; Humans; Isoxazoles; Male; Obsessive-Compulsive Disorder; Piperidines; Risperidone; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tic Disorders; Tourette Syndrome | 1994 |
New developments in the treatment of obsessive-compulsive disorder.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Age Factors; Age of Onset; Antidepressive Agents, Second-Generation; Child; Clinical Trials as Topic; Clomipramine; Clonazepam; Cognitive Behavioral Therapy; Haloperidol; Humans; Immunoglobulins, Intravenous; Obsessive-Compulsive Disorder; Penicillins; Plasmapheresis; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1997 |
[Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders].
Topics: Antipsychotic Agents; Autistic Disorder; Body Dysmorphic Disorders; Clomipramine; Comorbidity; Disruptive, Impulse Control, and Conduct Disorders; Drug Therapy, Combination; Feeding and Eating Disorders; Haloperidol; Humans; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Tourette Syndrome | 2011 |
9 trial(s) available for haloperidol and clomipramine
Article | Year |
---|---|
Clomipramine: an antiobsessive drug.
Topics: Anxiety; Behavior Therapy; Clinical Trials as Topic; Clomipramine; Compulsive Behavior; Depressive Disorder; Diazepam; Haloperidol; Humans; Imipramine; Nortriptyline; Obsessive Behavior; Obsessive-Compulsive Disorder; Phobic Disorders; Psychological Tests | 1986 |
[Quantitative EEG analysis of a single dose of psychotropic drugs in healthy probands].
Topics: Adult; Arousal; Brain; Carbamazepine; Clomipramine; Desipramine; Diazepam; Electroencephalography; Evoked Potentials; Female; Haloperidol; Humans; Imipramine; Male; Psychotropic Drugs | 1986 |
[Treatment of severe chronic pains with a combination of thymoleptics and neuroleptics (author's transl)].
Topics: Adult; Antidepressive Agents; Atropine; Chlorpromazine; Clinical Trials as Topic; Clomipramine; Drug Combinations; Female; Haloperidol; Humans; Imipramine; Male; Methotrimeprazine; Middle Aged; Morphine; Neoplasms; Pain; Papaverine; Tranquilizing Agents | 1974 |
[Controlled study on the possible benefits of combination therapy with chlorimipramine and haloperidol inpatients with endogenous depression].
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Drug Combinations; Female; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Random Allocation; Self-Assessment; Time Factors | 1984 |
A multicenter controlled trial in phobic-obsessive psychoneurosis. The effect of chlorimipramine and of its combinations with haloperidol and diazepam.
Topics: Adult; Aged; Clinical Trials as Topic; Clomipramine; Diazepam; Dose-Response Relationship, Drug; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; MMPI; Phobic Disorders; Random Allocation | 1981 |
A comparison of live and videotape ratings: clomipramine and haloperidol in autism.
Topics: Autistic Disorder; Child; Child, Preschool; Clomipramine; Double-Blind Method; Female; Haloperidol; Humans; Male; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome | 1995 |
Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover study.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Autistic Disorder; Basal Ganglia Diseases; Clomipramine; Cross-Over Studies; Double-Blind Method; Female; Haloperidol; Humans; Male; Psychiatric Status Rating Scales; Stereotyped Behavior; Treatment Outcome | 2001 |
Relationship between prolactin responses to ECT and dopaminergic and serotonergic responsivity in depressed patients.
Topics: Adult; Aged; Clomipramine; Depressive Disorder, Major; Dopamine Antagonists; Electroconvulsive Therapy; Haloperidol; Humans; Male; Middle Aged; Prolactin; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors | 2002 |
Serotonergic and dopaminergic neuroendocrine responses of male depressive patients before and after a therapeutic ECT course.
Topics: Adult; Aged; Clomipramine; Depressive Disorder, Major; Dopamine Antagonists; Electroconvulsive Therapy; Haloperidol; Humans; Hydrocortisone; Male; Middle Aged; Prolactin; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2002 |
65 other study(ies) available for haloperidol and clomipramine
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Pyrroloisoquinoline antidepressants. 2. In-depth exploration of structure-activity relationships.
Topics: Animals; Antidepressive Agents; Blepharoptosis; Brain; Catecholamines; Chemical Phenomena; Chemistry; Dopamine; Isoquinolines; Male; Molecular Conformation; Motor Activity; Norepinephrine; Pyrroles; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Structure-Activity Relationship; Synaptosomes; Tetrabenazine | 1987 |
Synthesis and anxiolytic activity of a series of pyrazino[1,2-a][1,4]benzodiazepine derivatives.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Apomorphine; Benzodiazepines; Diazepam; Guinea Pigs; Histamine Antagonists; In Vitro Techniques; Male; Norepinephrine; Pyrazines; Rats; Receptors, Drug; Serotonin | 1980 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease.
Topics: Animals; Cattle; Cell Line; Cell Line, Tumor; Chagas Disease; Drug Evaluation, Preclinical; Hepatocytes; High-Throughput Screening Assays; Humans; Image Processing, Computer-Assisted; Muscle, Skeletal; Parasitic Sensitivity Tests; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets.
Topics: Animals; Cattle; Cells, Cultured; Computer Simulation; Cornea; Drug-Related Side Effects and Adverse Reactions; Fibroblasts; Lipidoses; Lysosomal Storage Diseases; Models, Molecular; Pharmaceutical Preparations; Phospholipids; Structure-Activity Relationship; Thermodynamics | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
A high-throughput cell-based method to predict the unbound drug fraction in the brain.
Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
[The treatment of chronic pain symptoms with psychotropic drugs (author's transl)].
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Bone Diseases; Clomipramine; Drug Therapy, Combination; Haloperidol; Humans; Imipramine; Neoplasms; Neuralgia; Pain; Palliative Care; Promazine; Trimipramine | 1976 |
Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy.
Topics: Animals; Catalepsy; Central Nervous System; Clomipramine; Drug Interactions; Haloperidol; Humans; Male; Methysergide; Quipazine; Rats; Serotonin; Time Factors | 1979 |
Hyperthermia induced by amphetamine, p-chloroamphetamine and fenfluramine in the rat-1.
Topics: Amphetamine; Amphetamines; Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Body Temperature; Clomipramine; Cyproheptadine; Depression, Chemical; Disulfiram; Dopamine; Female; Fenclonine; Fenfluramine; Haloperidol; Hypothalamus; Methyltyrosines; p-Chloroamphetamine; Rats; Serotonin; Stimulation, Chemical; Time Factors | 1975 |
[The treatment of chronic low back pain with psychotropic drugs (author's transl)].
Topics: Antidepressive Agents; Back Pain; Central Nervous System; Chronic Disease; Clomipramine; Drug Therapy, Combination; Haloperidol; Humans; Imipramine; Methotrimeprazine; Peripheral Nerves; Psychotropic Drugs; Tranquilizing Agents | 1977 |
[The treatment of chronic pain with psychotropic drugs].
Topics: Clomipramine; Haloperidol; Humans; Imipramine; Methotrimeprazine; Muscle Contraction; Pain; Psychotropic Drugs; Receptors, Adrenergic, beta; Receptors, Dopamine | 1978 |
Clinical significance of monitoring plasma levels of psychotropic drugs.
Topics: Adult; Child; Chronic Disease; Clomipramine; Haloperidol; Humans; Mental Disorders; Parasympatholytics; Psychotropic Drugs; Schizophrenia | 1979 |
A 5-hydroxytryptamine-like mode of anorectic action for 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212).
Topics: 5,6-Dihydroxytryptamine; Animals; Appetite Depressants; Clomipramine; Female; Haloperidol; p-Chloroamphetamine; Piperazines; Pyrazines; Raphe Nuclei; Rats; Serotonin; Serotonin Antagonists | 1978 |
The use of psychotropic drugs in the treatment of chronic, severe pains.
Topics: Chronic Disease; Clomipramine; Drug Evaluation; Drug Therapy, Combination; Haloperidol; Humans; Imipramine; Pain, Intractable; Psychotropic Drugs | 1976 |
Inhibition of prostaglandin synthetase by psychotropic drugs.
Topics: Amitriptyline; Animals; Anthracenes; Antidepressive Agents; Arachidonic Acids; Cattle; Chlorpromazine; Clomipramine; Desipramine; Enzyme Inhibitors; Haloperidol; Imipramine; Male; Mixed Function Oxygenases; Prostaglandins; Psychotropic Drugs; Seminal Vesicles | 1975 |
Tourette's syndrome and treatment with clomipramine hydrochloride.
Topics: Adult; Clomipramine; Drug Administration Schedule; Haloperidol; Humans; Male; Obsessive-Compulsive Disorder; Tourette Syndrome | 1991 |
[ICU syndrome].
Topics: Aged; Anxiety; Benzodiazepines; Clomipramine; Critical Care; Delirium; Depressive Disorder; Female; Hallucinations; Haloperidol; Humans; Intensive Care Units; Syndrome | 1991 |
Anti-depressants and anti-convulsants for the treatment of neuropathic pain syndromes in cancer patients.
Topics: Analgesics; Anticonvulsants; Antidepressive Agents; Clomipramine; Drug Therapy, Combination; Haloperidol; Humans; Maprotiline; Neoplasm Metastasis; Neoplasms; Neuralgia; Pain Measurement | 1991 |
Inhibition of chlorpromazine-induced catalepsy by the 5-HT-1A ligands pindolol and buspirone in mice.
Topics: Animals; Buspirone; Catalepsy; Chlorpromazine; Clomipramine; Female; Haloperidol; Male; Mice; Pindolol; Receptors, Serotonin | 1990 |
Lithium increases 5-HT-mediated prolactin release.
Topics: Clomipramine; Haloperidol; Humans; Hydrocortisone; Infusions, Intravenous; Lithium; Male; Metoclopramide; Prolactin; Serotonin; Time Factors | 1989 |
Pharmacological modulation of beta-endorphin in rat peritoneal macrophages.
Topics: 5-Hydroxytryptophan; Animals; beta-Endorphin; Bromocriptine; Central Nervous System; Clomipramine; Haloperidol; Immunity, Cellular; Macrophages; Male; Metergoline; Peritoneum; Rats; Rats, Inbred Strains; Serotonin | 1989 |
[Combined infusion analgesia--an alternative concept in postoperative pain therapy].
Topics: Analgesics; Analgesics, Opioid; Clomipramine; Dipyrone; Drug Therapy, Combination; Gastrectomy; Haloperidol; Humans; Infusions, Parenteral; Middle Aged; Pain, Postoperative; Tramadol | 1986 |
Influence of neuroleptics on the metabolism of tricyclic antidepressants--in vitro experiments with rat liver microsomes.
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Drug Interactions; Female; Haloperidol; Imipramine; In Vitro Techniques; Microsomes, Liver; Perazine; Rats; Rats, Inbred Strains | 1986 |
Central dopaminergic and noradrenergic receptor blockade in a patient with neuroleptic malignant syndrome.
Topics: Clomipramine; Female; Haloperidol; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Dopamine | 1986 |
[A case report of death from neuroleptic malignant syndrome].
Topics: Adult; Cause of Death; Clomipramine; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome | 1988 |
[Polygraphic therapy control in Gilles de la Tourette syndrome--a case report].
Topics: Adult; Arousal; Cerebral Cortex; Clomipramine; Drug Therapy, Combination; Electroencephalography; Electromyography; Evoked Potentials; Female; Haloperidol; Humans; Tourette Syndrome | 1986 |
Capgras syndrome in senile dementia of the Alzheimer type.
Topics: Aged; Alzheimer Disease; Capgras Syndrome; Clomipramine; Female; Haloperidol; Humans; Psychotic Disorders | 1985 |
Role of monoamines in the anorexigenic actions of fenfluramine, amphetamine and p-chloromethamphetamine.
Topics: Amphetamine; Animals; Appetite Depressants; Biogenic Amines; Chlorine; Clomipramine; Cyproheptadine; Dextroamphetamine; Eating; Ergolines; Female; Fenfluramine; Haloperidol; Methamphetamine; Methyltyrosines; Methysergide; Rats; Rats, Inbred Strains | 1974 |
Therapeutic drug monitoring of psychotropic drugs in children.
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Child; Child, Preschool; Chlorpromazine; Clomipramine; Dose-Response Relationship, Drug; Half-Life; Haloperidol; Humans; Imipramine; Kinetics; Mental Disorders; Nortriptyline | 1983 |
Tricyclic antidepressants.
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Brain; Clomipramine; Dopamine; Haloperidol; Homovanillic Acid; Hydroxyindoleacetic Acid; Imipramine; Male; Rats; Receptors, Dopamine; Time Factors | 1980 |
The mechanism of action of delta 9-tetrahydrocannabinol on body temperature in mice.
Topics: Animals; Biogenic Amines; Body Temperature; Clomipramine; Dronabinol; Fenclonine; Haloperidol; Male; Methysergide; Mice; Phenoxybenzamine | 1980 |
The TSH-response to TRH: A possible predictor of outcome to antidepressant and neuroleptic treatment.
Topics: Adolescent; Adult; Aged; Clomipramine; Depressive Disorder; Female; Haloperidol; Humans; Middle Aged; Prognosis; Thyrotropin; Thyrotropin-Releasing Hormone | 1983 |
TSH-response patterns to TRH stimulation may indicate therapeutic mechanisms of antidepressant and neuroleptic drugs.
Topics: Adult; Clomipramine; Depressive Disorder; Female; Haloperidol; Humans; Prognosis; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thyrotropin; Thyrotropin-Releasing Hormone | 1984 |
Repeated treatment with antidepressant drugs prevents salbutamol-induced hypoactivity in rats.
Topics: Albuterol; Animals; Antidepressive Agents; Clomipramine; Diazepam; Haloperidol; Male; Mianserin; Motor Activity; Nialamide; Rats; Rats, Inbred Strains | 1984 |
Serial application of clonidine tests during antidepressive treatment with chlorimipramine.
Topics: Adult; Clomipramine; Clonidine; Depressive Disorder; Drug Therapy, Combination; Female; Growth Hormone; Haloperidol; Humans; Male; Middle Aged | 1984 |
[Effect of psychodrugs on morphine effectivity (author's transl)].
Topics: Analgesia; Animals; Apomorphine; Clomipramine; Haloperidol; Male; Mice; Morphine; Time Factors | 1980 |
Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder.
Topics: Animals; Clomipramine; Conditioning, Operant; Desipramine; Diazepam; Disease Models, Animal; Drinking Behavior; Fluoxetine; Haloperidol; Male; Obsessive-Compulsive Disorder; Rats; Rats, Wistar; Reinforcement Schedule; Selective Serotonin Reuptake Inhibitors | 1993 |
Three cases of alopecia areata induced by zotepine.
Topics: Adult; Alopecia; Alopecia Areata; Antipsychotic Agents; Autoimmune Diseases; Carbamazepine; Clomipramine; Depressive Disorder; Diagnosis, Differential; Dibenzothiepins; Female; Haloperidol; Humans; Middle Aged; Schizophrenia | 1993 |
Opposite effects of PCA and chlorimipramine on ICSS and on its facilitation by amphetamine.
Topics: Animals; Brain; Clomipramine; Dextroamphetamine; Discrimination Learning; Dopamine; Drug Interactions; Fenfluramine; Haloperidol; Male; p-Chloroamphetamine; Rats; Rats, Sprague-Dawley; Self Stimulation; Serotonin; Synaptic Transmission; Time Factors | 1994 |
Schizophrenia, obsessive-compulsive disorder, and Tourette's syndrome: a case of triple comorbidity.
Topics: Adult; Basal Ganglia Diseases; Brain; Clomipramine; Comorbidity; Female; Haloperidol; Humans; Obsessive-Compulsive Disorder; Prolactin; Schizophrenia; Tourette Syndrome | 1993 |
Differential response of psychotic and obsessive symptoms to risperidone in an adolescent.
Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Antipsychotic Agents; Clomipramine; Hallucinations; Haloperidol; Humans; Male; Obsessive-Compulsive Disorder; Psychotic Disorders; Risperidone; Sertraline; Trifluoperazine | 1996 |
Effects of psychoactive drugs on temporal discrimination in rats.
Topics: Animals; Atropine; Clomipramine; Desipramine; Diazepam; Discrimination Learning; Discrimination, Psychological; Haloperidol; Male; Nicotine; Psychotropic Drugs; Rats; Rats, Wistar; Scopolamine | 1997 |
Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone.
Topics: Adult; Antipsychotic Agents; Clomipramine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Humans; Male; Prolactin; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Risperidone; Schizophrenia; Serotonin Antagonists | 2001 |
Changes in central serotonergic function as a correlate of duration of illness in paranoid schizophrenia.
Topics: Adolescent; Adult; Brain; Chronic Disease; Clomipramine; Dopamine; Haloperidol; Humans; Male; Prognosis; Prolactin; Psychiatric Status Rating Scales; Schizophrenia, Paranoid; Serotonin; Synaptic Transmission | 2002 |
Prolactin responses to acute clomipramine and haloperidol of male schizophrenic patients in a drug-free state and after treatment with clozapine or with olanzapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clomipramine; Clozapine; Haloperidol; Humans; Hypothalamo-Hypophyseal System; Male; Middle Aged; Olanzapine; Pirenzepine; Prolactin; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Receptors, Serotonin; Schizophrenia; Treatment Outcome | 2002 |
Re: Clomipramine vs. Haloperidol in the treatment of autistic disorder: a double-blind, placebo, crossover study.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clinical Trials as Topic; Clomipramine; Cross-Over Studies; Double-Blind Method; Haloperidol; Humans | 2002 |
Haloperidol both prevents and reverses quinpirole-induced nonregulatory water intake, a putative animal model of psychogenic polydipsia.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Benzodiazepines; Clomipramine; Clozapine; Disease Models, Animal; Dose-Response Relationship, Drug; Drinking; Haloperidol; Male; Olanzapine; Piperazines; Pyrroles; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Thiazepines | 2008 |
Extrapyramidal side effects in a blue and gold macaw (Ara ararauna) treated with haloperidol and clomipramine.
Topics: Animals; Basal Ganglia Diseases; Bird Diseases; Clomipramine; Dopamine Antagonists; Female; Haloperidol; Psittaciformes; Selective Serotonin Reuptake Inhibitors | 2008 |
Clomipramine, but not haloperidol or aripiprazole, inhibits quinpirole-induced water contrafreeloading, a putative animal model of compulsive behavior.
Topics: Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Clomipramine; Compulsive Behavior; Conditioning, Operant; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drinking Behavior; Haloperidol; Male; Piperazines; Quinolones; Quinpirole; Rats; Rats, Sprague-Dawley | 2011 |
Ritualistic chewing behavior induced by mCPP in the rat is an animal model of obsessive compulsive disorder.
Topics: Animals; Behavior, Animal; Clomipramine; Diazepam; Disease Models, Animal; Dopamine Antagonists; Fluvoxamine; GABA Modulators; Haloperidol; Male; Mastication; Mianserin; Obsessive-Compulsive Disorder; Piperazines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists | 2013 |